Obesity Funding, AI and Clinical Trial Diversity: Where The NIH Director Nominee Stands

Monica Bertagnolli’s Senate HELP confirmation hearing did not produce many displays of bipartisanship, but it did illuminate many of the key challenges facing NIH on topics that impact pharma companies.